Gyre Therapeutics (GYRE) logo

Gyre Therapeutics (GYRE) stock

Market cap $677MShares as of Aug 1

$6.07
+3.76%

As of Monday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score GYRE. It is too thinly traded for a fair Quality Score.

Healthcare · Biotech

NextQ1 2027“…Investigational New Drug (IND) applications in the United States and/or China in the first quarter of 2027…”Filing with regulators · SEC filing · Aug 7
Cash$57.3M in cash. One of the last four quarters brought cash in while the others used it.On Jun 30

Follow GYRE's news. Pro members can get an alert when Gyre Therapeutics files news, and see its trials, share raises, and its CEO's filings.

Get an alert when GYRE files newsSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,191 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$57.3M in cash. One of the last four quarters brought cash in while the others used it.On Jun 30

What's next for GYRE, and how long its cash lasts

Next step the company has named

Q1 2027“…Gyre expects to submit Investigational New Drug (IND) applications in the United States and/or China in the first quarter of 2027 for two additional Cullgen degrader assets: CG923308, a…”Filing with regulators · SEC filing · Aug 7

What it means: a filing asks regulators to approve a drug for sale. Once it is complete and accepted, the FDA sets a decision date, and we show it here.

Lead program
CG923308

For Pro members: 1 more milestone and 53 filings.

Cash runway Jun 30 balance sheet

$57.3M in cash

One of the last four quarters brought cash in while the others used it, so an average says little about the next.

What it means: a runway is counted only when each of the last four quarters used cash.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

  • Shelf registration (S-3, filed Nov 14, 2024)
  • At-the-market share sales program (424B5, filed Nov 27, 2024)

For Pro members: 2 raises and their amounts, and the share count against a year ago.

Insiders

Chief Operating Officer Weiguo Ye sold 11,000 shares on Jun 18. 8 more insider trades this year.

From Form 4: open-market buys and sales only.

For Pro members: every trade, and Ying Luo’s 7 filings and quotes.

Get an alert when GYRE files newsSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

10 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 168 dates, ranked →

GYRE's latest filings

33 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why GYRE isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. GYRE trades about 129,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.

Straight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

The price on this page is delayed at least 15 minutes.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.